{"doi":"10.1089/can.2022.0079","title":"Delta-8 THC Retail Availability, Price, and Minimum Purchase Age","abstract":"Background: Retail sales of Delta-8 tetrahydrocannabinol (THC) products have increased in the U.S. market since the passing of the 2018 Farm Bill, and there is currently little regulation of marketing/sales and limited related safety standards in many states. After thousands of calls to poison control centers (40% for individuals under 18 years old and 70% requiring health care facility evaluation), the Food and Drug Administration issued warnings on Delta-8 THC products, stating their psychoactive effects and that some manufacturers may synthesize Delta-8 using unsafe household chemicals. The current study describes the Delta-8 THC retail sales environment in Fort Worth, Texas. Given its relatively inexpensive manufacturing and that low prices are a major determinant of cannabis use, the price of Delta-8 THC products was examined. This study also examined whether retail outlets in areas with greater socioeconomic deprivation had higher odds of selling Delta-8 THC products. This is important because if Delta-8 THC retailers are disproportionately located in more socioeconomically deprived communities, residents of these communities can more easily access these products and may have higher risk of adverse consequences. Methods: Potential Delta-8 THC retailers were selected by identifying lists of current retail locations with alcohol, cannabidiol, and/or tobacco licenses in Fort Worth. Trained research assistants called outlets in September and October 2021 to query about sales of products containing Delta-8 THC. The response rate was 69% ( n =1,223). Outlets' 9-digit zip codes were merged with Area Deprivation Index scores. Products and purported minimum age were described. Chi-squared and Student's t -tests were used. Results: Eleven percent of outlets ( n =133) reported selling Delta-8 THC. Ninety-six percent sold vapes and/or “flower” (i.e., hemp leaves coated with Delta-8 THC distillate) and 76% sold edibles. Among the least expensive products available, edibles cost, on average, $8.58 less than flower/vapes ( p <0.001). Outlets that sold Delta-8 THC were located in areas with greater deprivation ( p =0.02). Most reported a minimum purchase age of 21; however, 4% reported 18 years or no minimum age. Conclusions: Delta-8 THC retail outlets were disproportionately located in areas with more socioeconomic deprivation. Legal intervention such as zoning, minimum age, and tax laws may help reduce Delta-8 THC-related disparities.","journal":"Cannabis and Cannabinoid Research","year":2022,"id":248677,"datarank":0.0,"base_score":0.0,"endowment":0.0,"self_citation_contribution":0.0,"citation_network_contribution":0.0,"self_endowment_contribution":0.0,"citer_contribution":0.0,"corpus_percentile":null,"corpus_rank":null,"citation_count":30,"citer_count":0,"citers_with_citation_signal":0,"citers_with_endowment":0,"datacite_reuse_total":0,"is_dataset":false,"is_dataset_confidence":0.9554,"is_data_producer":false,"deposit_databanks":null,"is_oa":true,"file_count":0,"downloads":0,"has_version_chain":false,"published_date":"2022-01-01","fair_score":null,"fair_percentile":null,"algorithm_id":"datarank_citation_only_1hop_v6","ranking_scope":"data_only","authors":[{"id":792926,"name":"Cassidy R. LoParco","orcid":"0000-0003-4206-4179","position":1,"is_corresponding":false},{"id":828421,"name":"Andrew Walker","orcid":"0000-0002-4216-2396","position":2,"is_corresponding":false},{"id":337986,"name":"Melvin D. Livingston","orcid":"0000-0002-6327-8910","position":3,"is_corresponding":false},{"id":533073,"name":"Pamela J. Trangenstein","orcid":"0000-0003-2823-7790","position":4,"is_corresponding":false},{"id":888800,"name":"Sofia E. Olsson","orcid":null,"position":5,"is_corresponding":false},{"id":888801,"name":"Kayla K. McDonald","orcid":null,"position":6,"is_corresponding":false},{"id":521011,"name":"R. Andrew Yockey","orcid":"0000-0002-2140-2418","position":7,"is_corresponding":false},{"id":393564,"name":"Justin M. Luningham","orcid":"0000-0002-5037-9149","position":8,"is_corresponding":false},{"id":397810,"name":"Amanda Y. Kong","orcid":"0000-0002-8361-7342","position":9,"is_corresponding":false},{"id":888187,"name":"Doug Henry","orcid":"0000-0003-3627-9974","position":10,"is_corresponding":false},{"id":374490,"name":"Scott T. Walters","orcid":"0000-0003-4074-6141","position":11,"is_corresponding":false},{"id":888802,"name":"Dennis L. Thombs","orcid":null,"position":12,"is_corresponding":false},{"id":696836,"name":"David H. Jernigan","orcid":"0000-0002-0789-6917","position":13,"is_corresponding":false},{"id":379509,"name":"Matthew E. Rossheim","orcid":"0000-0003-4388-5251","position":0,"is_corresponding":true}],"reference_count":23,"raw_metadata":null,"created_at":"2026-07-19T00:24:14.794521Z","pmid":"36342930","pmcid":null,"fwci":null,"citation_percentile":null,"influential_citations":0,"oa_status":null,"license":null,"views":0,"total_file_size_bytes":0,"version_count":0,"fair_f":null,"fair_a":null,"fair_i":null,"fair_r":null,"fair_zscore":null,"fair_rationale":null,"fair_model":null,"fair_agent_version":null,"fair_fulltext_source":null,"fair_has_llm":null,"fair_computed_at":null,"clinical_trials":[],"software_tools":[],"db_accessions":[],"linked_datasets":[],"topics":[]}